RMI is dedicated to providing high quality consultative services on pharmacokinetics & drug metabolism including data analysis, data interpretation, issue resolution, strategic planning, due diligences and training tailored specifically for the industry.

The cliental includes biotechnology companies, the pharmaceutical industry, contract research organizations and venture capitalists.


  • Multidimensional integration of non-clinical data optimizing pharmacokinetic attributes
  • Innovative approaches for early development e.g. microdosing
  • Industry focused and interactive training in Pharmacokinetics & Drug Metabolism


  • Shorter project cycle times
  • Lower attrition in later development
  • Quality key decision made earlier
  • Better return on investment